Founded in 1965, Medizinische Hochschule Hannover (MHH) is one of the world’s leading university medical centres. The institution focuses on interdisciplinary research and has strong collaborative links to many academic and industrial scientific organisations worldwide. Building on broad expertise in medicine and life sciences, MHH scientists study human diseases and develop innovative strategies for diagnosis, prevention and therapy.
Renowned for its clinical excellence, MHH develops novel treatment options based on small compounds, biomaterials, cell and gene therapy, as well as tissue engineering. The institution’s clinical research area includes a state-of-the-art trial centre.
The planned clinical trial will be carried out in the Division of Paediatric Gastroenterology and Hepatology (Prof. Dr. med. Ulrich Baumann, Dr. med N. Junge) in close collaboration with the Translational Department of Cell and Gene Therapy (Prof. Dr. med. Michael Ott) who performed the first hepatocyte transplantation in Germany and has great experience and knowledge on the scientific field of liver based gene therapy. The Division of Paediatric Gastroenterology and Hepatology in the Children´s Hospital at MHH runs a busy liver transplant unit and currently looks after the biggest cohort of liver transplanted children in Germany. The group is an international referral centre for children with liver disease and the only German representative in the European Reference Network (ERN) TRANSPLANTCHILD. There is further membership in other ERNs such as RARE LIVER or METABO.
Staff members involved
- Ulrich BaumannTeam Leader
- Michael OttDeputy Team Leader
- Norman JungeDeputy Team Leader